Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 2 Disease characteristics of the patients

From: Significantly impaired shoulder function in the first years of rheumatoid arthritis: a controlled study

Variable Patients (n = 103)
Disease duration (months) 20.3 (8.5)
19.0 (6.0; 36.0)
DAS28, 0–10 3.82 (1.37)
3.87 (1.00; 7.41)
n = 96
Rheumatoid factor positive, yes 81 (78.6 %)
Anti-CCP, yes 74 (75.5 %)
n = 98
Rheumatoid arthritis erosions, yes 39 (39.8 %)
DMARDs 91 (89.2 %)
Anti-TNF treatment 14 (13.6 %)
Health Assessment Questionnaire, 0–3 0.60 (0.55)
0.50 (0.00; 2.63)
n = 102
  1. For categorical variables, number (percentage) is presented. For continuous variables, mean (standard deviation) or median (minimum; maximum) per participant is presented
  2. anti-CCP anti-cyclic citrullinated peptide, DAS28 DAS28, Disease Activity Score of 28 joints, DMARD disease-modifying anti-rheumatic drug, TNF tumour necrosis factor